.Pharmacolibrary.Drugs.ATC.B.B01AB04 .Pharmacolibrary.Drugs.ATC.B.B01AB04| name: | Dalteparin | |
| ATC code: | B01AB04 | route: | subcutaneous |
| compartments: | 1 | |
| dosage: | 5000 | mg |
| volume of distribution: | 0.07 | L |
| clearance: | 1.68 | mL/min/kg |
| other parameters in model implementation | ||
Dalteparin is a low molecular weight heparin (LMWH) used as an anticoagulant for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and for prophylaxis in patients undergoing surgery or at increased risk of thromboembolic events. It is approved and widely used today for these indications.
Pharmacokinetic parameters in healthy adult volunteers (both male and female) after single subcutaneous injection.
Damle, B, et al., & Sweeney, K (2021). Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous Thromboembolism. Journal of clinical pharmacology 61(2) 172–180. DOI:10.1002/jcph.1716 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32827160
Howard, PA (1997). Dalteparin: a low-molecular-weight heparin. The Annals of pharmacotherapy 31(2) 192–203. DOI:10.1177/106002809703100212 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9034422
Yu, L, et al., & Guo, R (2018). Pharmacodynamic properties and bioequivalence of dalteparin sodium subcutaneous injection in healthy Chinese male subjects. Xenobiotica; the fate of foreign compounds in biological systems 48(4) 376–381. DOI:10.1080/00498254.2017.1316021 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28375032